Cargando…
In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon
BACKGROUND: Thalidomide and its analogs, lenalidomide and pomalidomide (referred to as immunomodulatory imide drugs or IMiDs) have been known to treat multiple myeloma and other hematologic malignancies as well as to cause teratogenicity. Recently the protein cereblon was identified as the primary t...
Autores principales: | Murai, Takahiro, Kawashita, Norihito, Tian, Yu-Shi, Takagi, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949186/ https://www.ncbi.nlm.nih.gov/pubmed/27478739 http://dx.doi.org/10.1186/s40064-016-2761-9 |
Ejemplares similares
-
Novel Concepts for Drug Hypersensitivity Based on the Use of Long-Time Scale Molecular Dynamic Simulation
por: Murai, Takahiro, et al.
Publicado: (2016) -
PB1958: IN SILICO ANALYSIS OF SYNONYMOUS AND NON-SYNONYMOUS SNPS OF THE HUMAN CEREBLON (CRBN) GENE: AN IMPORTANT GENE IN IMMUNOMODULATORY DRUGS (IMIDS)-BASED TREATMENT OF MULTIPLE MYELOMA PATIENTS
por: Güler, M., et al.
Publicado: (2022) -
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021) -
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
por: Peach, Megan L., et al.
Publicado: (2020) -
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
por: Gemechu, Yohannes, et al.
Publicado: (2018)